Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 2/20 | 0.34 |
| ▸ | DRD2 | P14416 | 4/20 | 0.33 |
| ▸ | DRD3 | P35462 | 4/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.33 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11056944 | 0.80 | PTGS2 (0.40) | PTGS2P2RY6CA12CA9CYP2A6 | |
| SCHEMBL28309473 | 0.80 | PTGS2 (0.43) | PTGS2P2RY6CA12CA9CYP2A6 | |
| SCHEMBL13387495 | 0.80 | PTGS2 (0.43) | PTGS2P2RY6CA2CA12CA9 | |
| SCHEMBL20572420 | 0.72 | CA12 (0.41) | PTGS2CA1CA2CA12CA9 | |
| SCHEMBL11619301 | 0.72 | CA12 (0.47) | CA2CA12CA9CYP2A6 | |
| SCHEMBL24328792 | 0.69 | DAO (0.40) | PTGS2DRD2DRD3 | |
| SCHEMBL8207140 | 0.69 | DAO (0.40) | PTGS2P2RY6CA12CA9DRD2 | |
| SCHEMBL8207143 | 0.69 | DRD2 (0.42) | PTGS2P2RY6DRD2DRD3ABCB1 | |
| SCHEMBL11219476 | 0.68 | ABCB1 (0.39) | PTGS2ABCB1 | |
| SCHEMBL1479641 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1270550-B1 | Process for producing 3, 4-Dihydroxybenzonitrile | UBE INDUSTRIES (JP) | 2004-09-15 | — | — | EP | claimed |
| US-6573397-B2 | Chlorinating 3,4-methylenedioxybenzonitrile with sulfuryl chloride or chlorine in presence of promoter to form 2-chloro-benzo(1,3)dioxole-5-carbonitrile, hydrolyzing with water to produce 3,4-dihydroxybenzonitrile | UBE INDUSTRIES, LTD. (JP) | 2003-06-03 | — | — | US | claimed |
| US-20030009048-A1 | Process for producing 3,4-dihydroxybenzonitrile | UBE INDUSTRIES, LTD. | 2003-01-09 | — | — | US | claimed |
| EP-1270550-A1 | Process for producing 3, 4-Dihydroxybenzonitrile | Ube Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | claimed |
| EP-1270550-B1 | Process for producing 3, 4-Dihydroxybenzonitrile | UBE INDUSTRIES (JP) | 2004-09-15 | — | — | EP | disclosed |
| US-6573397-B2 | Chlorinating 3,4-methylenedioxybenzonitrile with sulfuryl chloride or chlorine in presence of promoter to form 2-chloro-benzo(1,3)dioxole-5-carbonitrile, hydrolyzing with water to produce 3,4-dihydroxybenzonitrile | UBE INDUSTRIES, LTD. (JP) | 2003-06-03 | — | — | US | disclosed |
| US-6573397-B2 | Chlorinating 3,4-methylenedioxybenzonitrile with sulfuryl chloride or chlorine in presence of promoter to form 2-chloro-benzo(1,3)dioxole-5-carbonitrile, hydrolyzing with water to produce 3,4-dihydroxybenzonitrile | UBE INDUSTRIES, LTD. (JP) | 2003-06-03 | — | — | US | disclosed |
| US-20030009048-A1 | Process for producing 3,4-dihydroxybenzonitrile | UBE INDUSTRIES, LTD. | 2003-01-09 | — | — | US | disclosed |
| US-20030009048-A1 | Process for producing 3,4-dihydroxybenzonitrile | UBE INDUSTRIES, LTD. | 2003-01-09 | — | — | US | disclosed |
| EP-1270550-A1 | Process for producing 3, 4-Dihydroxybenzonitrile | Ube Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1270550-A1 | Process for producing 3, 4-Dihydroxybenzonitrile | Ube Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009048-A1 | Process for producing 3,4-dihydroxybenzonitrile | BPNT1, DCUN1D4, CPN1 | PTGS2 2688/4885P2RY6 996/4885CA1 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.